NDRA ENDRA Life Sciences Inc.

NASDAQ
$4.47

ENDRA Life Sciences Inc. (NDRA) is expected to report earnings on November 13, 2026, after the market close. The consensus earnings estimate is a loss of $0.84 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.1% since its last earnings release on August 14, 2026.

ENDRA Life Sciences Beat Consensus Estimates
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · After Close
Earnings Whisper
-
vs ($0.84)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.91

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

Sector

Healthcare

Industry

Medical Instruments/Supply